FDA Approves Tocilizumab (Actemra) for Giant Cell Arteritis

The FDA has expanded the approved use of subcutaneous tocilizumab (Actemra, Hoffman LaRoche) to include treatment of adults with giant cell arteritis.
FDA Approvals …read more